aldose reductase inhibitors (Senju/National Eye Institute)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namealdose reductase inhibitors (Senju/National Eye Institute)
Drug Alias NameSJA-6063SJA-7059
ClassificationSmall molecules
Mechanisms of ActionAldose reductase inhibitorsThioredoxin reductase 1 inhibitors
TargetsAldose reductaseThioredoxin reductase 1
Therapy Area/IndicationsDiabetic cataractDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSenju Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Eye InstituteSenju Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetic cataractDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A